Results 51 to 60 of about 469 (114)

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report. [PDF]

Cardiol J, 2022
Fox H, Gummert JF, Sommer P, Knabbe C, Sohns C.   +4 more
europepmc   +1 more source

Use of levosimendan in patient with heart failure with reduced ejection fraction, clinical case [PDF]

Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroducere. O strategie utilizată în managementul insuficienței cardiace cu fracție de ejecție redusă (IC-FEr) este creșterea contractilității miocardice ...
Cernous,Alexandr, Cojocaru, Doina, Domenco, Marina, Rozmerița, Cristina, Vrabii, Valeriu   +4 more
core  

Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis. [PDF]

Cardiol J, 2021
Jaguszewski MJ, Gasecka A, Targonski R, Filipiak KJ, Szarpak L.   +4 more
europepmc   +1 more source

Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry. [PDF]

ESC Heart Fail, 2023
Codina P, Dobarro D, de Juan-Bagudá J, De Frutos F, Lupón J, Bayes-Genis A, Gonzalez-Costello J, Spanish LEVO‐D registry Collaborators.   +7 more
europepmc   +1 more source

Levosimendan in Cardiac Arrest (LeiCA): Protocol for a Randomized, Double-Blind, Phase II Clinical Trial. [PDF]

Acta Anaesthesiol Scand
Rysz S, Flam B, Hedberg M, Galmén K, Mårtensson J, Djärv T, Jonsson Fagerlund M.   +6 more
europepmc   +1 more source

Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. [PDF]

BMJ Open
Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL.   +5 more
europepmc   +1 more source

Outpatient 6-Hour Levosimendan Treatment as a Bridge to Heart Transplant. [PDF]

Arq Bras Cardiol, 2023
Gonçalves AV, Reis JP, Timóteo AT, Soares R, Pereira-da-Silva T, Gomes V, Moreira RI, Pombo D, Carvalho T, Correia C, Santos C, Ferreira RC.   +11 more
europepmc   +1 more source

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum. [PDF]

J Cardiovasc Pharmacol, 2022
Levijoki J, Pollesello P, Pollesello P, Grossini E, Papp Z.   +4 more
europepmc   +1 more source

A Comment on the use of Levosimendan for the Management of Right Ventricular Dysfunction in Patients Undergoing Mitral Valve Surgery. [PDF]

Ann Card Anaesth
Shah D, Korfiotis D, Zimbler N.
europepmc   +1 more source

Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft Dysfunction. [PDF]

Clin Transplant
Guzman-Bofarull J, Martín-Centellas A, Couto-Mallon D, Borràs R, Arenas-Loriente A, Rivas-Lasarte M, Segovia-Cubero J, Crespo-Leiro MG, García-Álvarez A, Farrero M.   +9 more
europepmc   +1 more source